Source: International Congress 2017 – Experimental PH
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Howell (Dublin, Ireland). Specific ligand for the innate repair receptor, ARA290, attenuates pulmonary hypertension in an elastase-induced murine model of emphysema. 2382

Member's Comments

No comment yet.

Related content which might interest you: Selective endothelin-A receptor blockade attenuates bleomycin-induced pulmonary inflammation and fibrosis in mice Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013 FPS-ZM1-induced blocking of RAGE alleviates elastase-induced emphysema development by preventing RAGE-DAMP-Nrf2 signaling Source: International Congress 2017 – From the bench: therapeutic approaches in COPD and emphysema Year: 2017 Characterisation of endogenous IL-33 using a model of Alternaria-induced pulmonary inflammation Source: Annual Congress 2012 - Cellular signalling mechanisms in the airways Year: 2012 Reduction of endogenous acetylcholine contributes to pulmonary inflammation in a model of emphysema in mice Source: Annual Congress 2012 - The many roads to lung injury Year: 2012 Effects of AT1 receptor blockade on pulmonary and systemic manifestations in a COPD/emphysema mouse model Source: Annual Congress 2009 - Preclinical models in drug development Year: 2009 IL-23 is essential to the development of elastase-induced pulmonary inflammation and emphysema Source: International Congress 2016 – New findings in mucosal immunology Year: 2016 Role of Toll-like receptor 4 in acute pulmonary inflammation induced by bacterial components in mice Source: Eur Respir J 2005; 26: Suppl. 49, 730s Year: 2005 Protective roles of mannose receptor in an experimental pulmonary fibrosis model Source: International Congress 2018 – Pulmonary fibrosis: from models to patients Year: 2018 Optimization of tissue targeting properties of macitentan, a new dual endothelin receptor antagonist, improves its efficacy in a rat model of pulmonary fibrosis associated with pulmonary arterial hypertension Source: Annual Congress 2011 - Treatment of human pulmonary hypertension Year: 2011 Protease-activated receptor-4 deficiency does not protect against bleomycin-induced pulmonary fibrosis in mice}, Source: Eur Respir J 2012; 40: 1056-1057 Year: 2012 Neutralization of CXCL12 reverses established pulmonary hypertension in the sugen-hypoxia rat model Source: International Congress 2017 – Experimental PH Year: 2017 Angiotensin II antagonism fails to ameliorate bleomycin-induced pulmonary fibrosis in mice Source: Eur Respir J 2005; 25: 708-714 Year: 2005 Cigarette smoke induced pulmonary emphysema is attenuated in CCR6 deficient mice Source: Annual Congress 2006 - Cell biology of asthma and COPD Year: 2006 Role of anti-proliferative therapy in PAH Source: Research Seminar 2008 - The Pulmonary Circulation: Scleroderma-Related Pulmonary Arterial Hypertension Year: 2008 Cigarette smoke-induced pulmonary inflammation, but not airway wall remodeling, is attenuated in CCR5 deficient mice Source: Annual Congress 2007 - The best of airway epithelial cells Year: 2007 Is there a role for endothelin-1 receptor antagonists in the treatment of lung fibrosis associated with pulmonary hypertension? Source: Eur Respir J, 52 (2) 1801287; 10.1183/13993003.01287-2018 Year: 2018 The role of expression of TLR 4 in bleomycin-induced pulmonary fibrosis in mice Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury Year: 2013 Preserved compliance and reduced inflammation after activation of peroxisome proliferator-activated receptor (PPAR)a in a murine model of acute lung injury Source: Annual Congress 2006 - Novel pathogenic aspects of acute lung injury and acute respiratory distress syndrome (ARDS) Year: 2006 Tiotropium inhibits pulmonary inflammation and remodelling in a guinea pig model of COPD Source: Eur Respir J 2011; 38: 789-796 Year: 2011 PAR-2 antagonist inhibits bleomycin-induced lung fibrosis. Source: International Congress 2019 – Extracellular matrix formation and remodelling in physiology and disease Year: 2019